Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 – ITM Isotope Technologies Munich SE (ITM), a ...

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning ... after the FDA laid out additional manufacturing standards for its lead ...

Every day, manufacturers continue to develop new, life-saving cancer treatments, and breakthroughs in oncology promise ... Development-phase companies need to establish distribution networks ...

Before this collaboration, Astellas Pharma had formed a joint venture with Yaskawa Electric Corporation, focusing on developing a cell therapy product manufacturing platform. "Astellas Pharma and JFCR ...